Jena, Germany

Marco Lehnort

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marco Lehnort: Innovator in Ophthalmological Laser Therapy

Introduction

Marco Lehnort is a notable inventor based in Jena, Germany. He has made significant contributions to the field of ophthalmology through his innovative inventions. His work focuses on enhancing the precision of laser therapy systems used in eye treatments.

Latest Patents

Marco Lehnort holds a patent for a positioning device designed for ophthalmological laser therapy. This device facilitates accurate positioning of the laser therapy system in relation to the patient's eye. The positioning device includes a first and a second recording unit that provide recording data from different directions. It also features a displacement unit that adjusts the relative position of the eye concerning the optical opening of the laser therapy system based on control commands. Additionally, the control unit generates these commands based on the recording data. The device may also include a display unit for showing the recording data and an input unit for entering data, allowing for enhanced control and accuracy during procedures.

Career Highlights

Marco Lehnort is associated with Carl Zeiss Meditec AG, a leading company in the field of medical technology. His work at this esteemed organization has allowed him to contribute to advancements in ophthalmological devices and therapies.

Collaborations

Throughout his career, Marco has collaborated with talented professionals, including Beate Böhme and Gregor Stobrawa. These collaborations have fostered an environment of innovation and excellence in the development of medical technologies.

Conclusion

Marco Lehnort's contributions to ophthalmological laser therapy through his innovative positioning device exemplify the impact of dedicated inventors in the medical field. His work continues to enhance the accuracy and effectiveness of eye treatments, benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…